Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.320.350.360.360.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.32 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.32
Mar20250.35
Mar20240.36
Mar20230.36
Mar20220.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.32
-8.57
Mar2025 0.35
-2.78
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹67,586.9 Cr 6.2% 9.1% 22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1% -2.9% 17.4% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr 1.8% 17% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -1.9% -1.9% 33.2% Stock Analytics
CIPLA ₹114,715.0 Cr 0.3% 0.7% -7.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.7% 3.5% -4.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

6.2%

9.1%

22.7%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses